The Company’s miR Sentinel™ Prostate Test is a new method to analyze small non-coding RNAs (sncRNA) derived from a simple, non-invasive urine specimen from age-eligible men.
Free presentations every day November 30 through December 21
An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasized, castration-resistant prostate cancer.
Rutgers researchers have discovered human gene markers that work together to cause metastatic prostate cancer.
Gallium 68 PSMA PET challenging certain guidelines?